| Literature DB >> 25245967 |
Vernon K Sondak1, Geoffrey T Gibney2.
Abstract
The management of unresectable metastatic melanoma has dramatically improved in recent years. Surgeons need to familiarize themselves with new drugs and the biology behind them, and ongoing clinical trials and new drugs in development for adjuvant therapy and treatment of metastatic disease.Entities:
Keywords: Adjuvant therapy; Immunotherapy; Melanoma; Targeted therapy
Mesh:
Substances:
Year: 2014 PMID: 25245967 DOI: 10.1016/j.suc.2014.07.007
Source DB: PubMed Journal: Surg Clin North Am ISSN: 0039-6109 Impact factor: 2.741